Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Once-Daily Single-Inhaler Triple Versus Dual Therapy in Patients With COPD (IMPACT Trial)

NCT05062304 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05062304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05062304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Once-Daily Single-Inhaler Triple Versus Dual Therapy in Patients With COPD (IMPACT Trial)
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
December 13, 2020
Completion date
July 22, 2021
Enrollment
17,281 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd